Xia et al. demonstrated that Cry2 suppresses the proliferation of breast cancer cells by repressing genes within the NF-κB pathway, whereas its acetylation attenuates this inhibitory effect [21]. The gene discussed is NFKB1; the disease is breast carcinoma.